Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Vorchheimer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Cardiology Reports|September 12, 2000
Current state of thrombolytic therapyD A Vorchheimer
JAMA|November 22, 2001
Inflammatory markers in coronary artery disease: let prevention douse the flamesD A Vorchheimer, V Fuster
European Heart Journal|July 20, 2002
Thrombin inhibitors in acute coronary artery diseaseD A Vorchheimer, V Fuster
The New England Journal of Medicine|January 16, 1997
Prevention of atherosclerosis in coronary-artery bypass graftsV Fuster, D A Vorchheimer
Circulation|February 19, 1998
Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safetyD A Vorchheimer, V Fuster
Current Cardiology Reports|August 16, 2001
Platelet glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: initiate treatment early or wait for the catheterization laboratory?D J Harnick, D A Vorchheimer
JAMA|April 27, 1999
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular diseaseD A Vorchheimer, J J Badimon, V Fuster
Journal of Thrombosis and Haemostasis : JTH|January 24, 2007
Normalization of platelet reactivity in clopidogrel-treated subjectsG Vilahur, B G Choi, M U Zafar, et al.
Atherosclerosis|November 4, 2000
Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statinsU Rauch, J I Osende, J H Chesebro, et al.
Journal of Thrombosis and Haemostasis : JTH|November 10, 2012
Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementationM U Zafar, C Santos-Gallego, D A Vorchheimer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Cardiology Reports|September 12, 2000
Current state of thrombolytic therapyD A Vorchheimer
JAMA|November 22, 2001
Inflammatory markers in coronary artery disease: let prevention douse the flamesD A Vorchheimer, V Fuster
European Heart Journal|July 20, 2002
Thrombin inhibitors in acute coronary artery diseaseD A Vorchheimer, V Fuster
The New England Journal of Medicine|January 16, 1997
Prevention of atherosclerosis in coronary-artery bypass graftsV Fuster, D A Vorchheimer
Circulation|February 19, 1998
Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safetyD A Vorchheimer, V Fuster
Current Cardiology Reports|August 16, 2001
Platelet glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: initiate treatment early or wait for the catheterization laboratory?D J Harnick, D A Vorchheimer
JAMA|April 27, 1999
Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular diseaseD A Vorchheimer, J J Badimon, V Fuster
Journal of Thrombosis and Haemostasis : JTH|January 24, 2007
Normalization of platelet reactivity in clopidogrel-treated subjectsG Vilahur, B G Choi, M U Zafar, et al.
Atherosclerosis|November 4, 2000
Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statinsU Rauch, J I Osende, J H Chesebro, et al.
Journal of Thrombosis and Haemostasis : JTH|November 10, 2012
Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementationM U Zafar, C Santos-Gallego, D A Vorchheimer, et al.
Pageof 2